Medical network - December 30, the ministry of commerce website yesterday (29 December) released the national medicine circulation industry development plan (2016-2020) "(hereinafter referred to as the" planning "), "modern medicine circulation system", "m&a", "transformation and upgrading", "Internet +", "health", and "to adapt to the reform of" two votes "key words" and information frequently jump out.
"Planning", "to 2020, forming a group network covering the whole country, large pharmaceutical circulation enterprises of high intensive and information technology degree. Pharmaceutical wholesale enterprises annual sales accounted for more than 90% of the total pharmaceutical wholesale market; drug retail enterprises annual sales accounted for more than 40% of the total retail market; rate of drug retail chain of more than 50%."
According to data released by the end of 2015 the CFDA, the total of 11959 pharmaceutical wholesale enterprises. At the same time, according to the ministry of commerce, in 2015 the drug circulation market size is 1.6613 trillion yuan, up 10% from a year earlier. If it is according to the proportion of growth, after five years will reach 2.6755 trillion yuan. Seized 90% is 2.408 trillion, the rest of the only 267.5 billion, under the condition of constant number, the average of the top 11859, an average of 22.56 million yuan each. And the average rate of pharmaceutical wholesale also several points, three points, even if it just earn 680000 yuan a year.
This is not as good as a cow point medicine generation earn more. So, taking big action in the country at the same time, is bound to have a large number of small and medium-sized pharmaceutical commercial firms collapsed.
Throughout, on the basis of existing, the upgrade of circulation order, industry concentration will further accelerate, used to cover a relatively weak market at the grass-roots level and small and medium-sized pharmaceutical circulation enterprises will get more policies to encourage and opportunities.
Internet medicine after several twists and turns, eventually did not take shape, but China is now the "Internet +" rapid economic development and is unable to avoid, "planning" special emphasis on promoting "Internet + medicine circulation", encourage enterprises to carry out the service innovation based on the Internet, the drug circulation channel and development pattern.
At the same time, support drug distribution enterprises and medical institutions and health care department, e-commerce enterprises to carry out the medical electrical business services, provide patients with over-the-counter "net book (medicine) shop", "net book (medicine) shop" and convenient services, promote the development of online fusion.
And to be a nationwide "two votes", will no doubt to the circulation rules and environment put forward new demands and new challenges - "planning" emphasizes: from the point of the external environment, the "two votes", "medicine to separate" the implementation of the policy and "Internet + medicine" and so on the mode of innovation, puts forward new requirements for industry transformation and upgrading of the post at this time, the ministry of commerce, pharmaceutical enterprise really needs a good experience, closely studied.
▍ focusing on five major tasks:
(a) reasonable planning industry layout, improve the drug distribution network.
Guiding the efficient allocation of resources. According to the medical and health undertakings development needs, according to the region's economic and social development level, urban and rural construction and development planning, the structure of the population and actual situation, in conjunction with the departments issuing annual number of drug consumption, medicine circulation enterprises, warehousing logistics capability, information such as coverage rates of retail pharmacies, guide the medicine circulation efficient allocation of resources. Cooperate with related department to optimize pharmaceutical logistics, retail enterprise network layout, network layout and regional development adapted to match, the drug supply and drug demand, avoid the repetitive construction and disorderly competition.
Build in urban and rural distribution network. Actively adapt to the reform of the "two votes" requirements, and gradually build large-scale backbone enterprise as the main body, small and medium enterprises as necessary complement modern medicine circulation network. Support strength, management norms, high credibility of the national and regional medicine circulation backbone enterprises, focus on the weak area of the logistics capability, integration, transformation and new has certain radiation ability of pharmaceutical logistics distribution center. Encourage large and medium-sized pharmaceutical wholesale enterprises, retail chain enterprises mainly for the convenience of business circle in the city, the new communities, rural and remote areas extend distribution and service network, giving full play to the advantages of postal enterprises, express delivery companies deliver network, realize effective covering of medicine circulation to the grassroots. To encourage small and medium-sized pharmaceutical circulation enterprises to develop specialization, characterization, doing fine designed, meet the multi-level market demand.
Enhance industry concentration. Encourage medicine circulation enterprises through merger and reorganization, the listed financing, issuing bonds and other way to do strong, do big, speed up the implementation scale, intensive and modern management. Support the development of small and medium-sized pharmaceutical circulation enterprises procurement alliance and pharmacy alliance, using 聯購 distribution, unified distribution, reduce operating costs, improve the organizational level. Encourage a zero integration, chaining operation, development of multiple formats of mixed operation.
(2) improve circulation management level, make modern medical providers.
Optimization of drug supply chain management. Support medicine circulation enterprises to strengthen supply chain management, improve the supply chain integration system, to provide supply chain upstream and downstream market development, price negotiation, online payment, financial support and other value-added services and integrated solutions, accelerate the development of transforming to pharmaceutical supply chain service provider. Use of cloud computing, big data and other modern information technology, integration of drug research and development production, circulation use, disease changes and patients' health demand and consumption habits of data information, strengthen the management of big data, analysis and application, for drug research and development institutions, judge the trend of the market, adjust the product structure and production enterprise medical institutions to improve drug choice, strengthen the rational use of drugs, to provide valuable data to support, improve the operation efficiency of the whole supply chain.
The development of modern green medicine logistics. Support drug circulation enterprises to promote the use of radio frequency identification, automatic sorting conveyor, satellite positioning and other advanced logistics technology, the development of upstream and downstream supply chain to connect, warehousing and transport resources effectively integrate, more collaborative distribution, a new type of modern green logistics cost economy pharmaceutical logistics. Support pharmaceutical cold-chain logistics system, encourage through collaborative logistics, joint distribution, realize the cold chain between enterprises resource sharing of the Internet. Construction in raw packaging, storage and maintenance, logistics distribution and traceability management in the integration of traditional Chinese medicine modern logistics system, improve the level of logistics organization, standardization and modernization of traditional Chinese medicinal materials. Promote the implementation of urban distribution vehicle unified identity management, convenient drug delivery vehicles.
(3) the business model innovation industry, expanding industry service function.
Promote the "Internet + medicine circulation". To promote information technology such as mobile Internet, Internet of things is widely used in the field of drug circulation, encourage enterprises to carry out the service innovation based on the Internet, the drug circulation channel and development pattern. Support drug distribution enterprises and medical institutions and health care department, e-commerce enterprises to carry out the medical electrical business services, provide patients with over-the-counter "net book (medicine) shop", "net book (medicine) shop" and convenient services, promote the development of online fusion.
Retail service mode innovation. In retail pharmacy information system and information system of medical institutions and medical insurance payment system docking process, encourage qualified retail pharmacies to undertake outpatient pharmacy service of medical institutions and other professional services. Guide the build system of chief pharmacist, with an emphasis on antimicrobial agents to guide rational drug use, and strive to improve the drug quality management of pharmaceutical service level. Positive publicity and reasonable application of antimicrobial drugs knowledge, improve the public awareness of the bacterial drug resistance crisis. Encourage the application of new technologies, such as wearable medical, doctors, dietitians, health management division, nurses and other professional talent, actively develop personal health management, disease prevention and slow management business, to build "service + product" new formats. Support the development of professional pharmacy, medicine (beauty) makeup shop, "pharmacy + clinic, the doctor of traditional Chinese medicine (national physician) the new retail such as mode of operation, advocate one-stop service and personalized service. Promote medical combination, encourage and medical and health institutions, community endowment institutions and domestic service agencies to provide for the aged home pension and health care services.
(4) "introduced to" and "going out", the combination of enhance the opening industry level.
Improve the utilization of foreign capital industry. To attract overseas drug distribution enterprises shall, in accordance with the relevant policies to expand domestic investment, to participate in domestic mergers and reorganization. Encourage domestic enterprises with the world's leading multinational enterprises set up joint venture company, to learn from foreign counterparts of advanced enterprise management idea and experience, all-round optimization operation mode, management mode and technology, improving the quality of private brand and core competence.
(5) to strengthen the construction of industry base, improve the ability of service industry.
Improving the industry standard system. Guide the medicine circulation industry association industry standard is scientific, advanced and forward-looking, to further improve the industry management and service standards. The interaction between drug circulation encoding rules or electronic data specification, gradually achieve efficient drug circulation and full traceability. For retail pharmacies classification management system, to carry out the retail pharmacy management service capability classification evaluation. Product specifications and grades for commonly used standards and traditional Chinese medicine packaging, storage, maintenance, back and other related standards. By conducting standard propaganda training, logo licensing, implementation of supervision work, guide the medicine circulation enterprises to carry out industry standards.
The previous page [1] [2] [3] The next page |
